OSSIUM HEALTH, INC.
SAN FRANCISCO, CA
What changed
NIH U01 · $0.5M · Sex specific differences in intestinal radiosensitivity
2mo agoGrant renewalMay 19, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 59 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R21 · $155k · non-dilutive
Aug 25, 2025UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAHA, SUBHRAJIT · NIAID · award ends Jul 31, 2027 · Phosphoglycerate mutase 5 a mitochondrial serin/threonine phosphatase a novel target to mitigate GI-ARS.
NIH RePORTER · NIH RePORTER 11224659 (opens the source filing in a new tab)
- Grant
R44 · $1.0M · non-dilutive
Aug 14, 2024OSSIUM HEALTH, INC. · PI JOHNSTONE, BRIAN H. · NIAID · award ends Jul 31, 2027 · Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury
NIH RePORTER · NIH RePORTER 11249415 (opens the source filing in a new tab)
- Grant
U01 · $519k · non-dilutive
Jun 1, 2024UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAHA, SUBHRAJIT · NIAID · award ends May 31, 2027 · Sex specific differences in intestinal radiosensitivity
NIH RePORTER · NIH RePORTER 11332834 (opens the source filing in a new tab)
- Grant
U01 · $677k · non-dilutive
Jul 21, 2022UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAHA, SUBHRAJIT · NIAID · award ends May 31, 2027 · Modulation of chemokine signaling to mitigate radiation induced inflammation
NIH RePORTER · NIH RePORTER 11326183 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources